UK markets closed

NIKKEI 225
38,460.08
+907.92(+2.42%)
HANG SENG
17,201.27
+372.34(+2.21%)
CRUDE OIL
82.94
-0.42(-0.50%)
GOLD FUTURES
2,337.40
-4.70(-0.20%)
DOW
38,377.78
-125.91(-0.33%)
Bitcoin GBP
52,029.90
-1,611.70(-3.00%)

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Endo International plc (0Y5F.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

0.0006

-0.0006

(-50.00%)

At close: 04:48PM BST

All

PR Newswire
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is expanding its voluntary recall to include seven lots of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulates in the product solution.
PR Newswire
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS®.
PR Newswire
Endo Announces Confirmation of Plan of Reorganization
Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that the United States Bankruptcy Court for the Southern District of New York has confirmed its Chapter 11 plan of reorganization (the "Plan"), clearing the path for the Company to successfully complete its financial restructuring. Under the Plan, substantially all of the Company's assets are being sold to a new entity, Endo, Inc., over 95% of which is owned by holders of the Company's first lien debt. The transaction